Gene Editing: The Future Of Genomic Medicine & Biotech Investing

Goldman Sachs Exchanges

English - March 23, 2022 20:55 - 17 minutes - ★★★★ - 769 ratings
Business Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Gene Editing: The Future of Genomic Medicine & Biotech Investing

Next Episode: How Policymakers are Navigating Stagflation Risk

In the latest episode of Exchanges at Goldman Sachs, Salveen Richter, Lead Analyst for the U.S. Biotechnology Sector in Goldman Sachs Research, explains how new innovations in gene editing are transforming the future of medicine and the greater biotech investment landscape.